DGAP-Adhoc: Commerzbank: Preliminary CET 1 ratio per end of

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Jul 25, 2016 at 3:45 PM

DGAP-Adhoc: Commerzbank: Preliminary CET 1 ratio per end of June 2016 at 11.5% - group net profit for the second quarter 2016 in line with consensus

Commerzbank Aktiengesellschaft / Key word(s): Miscellaneous 25.07.2016 21:37 Disclosure of an inside information according to Article 17 MAR, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- On the basis of preliminary figures Commerzbank posted an Operating profit of EUR342 million (Q2 2015: EUR419 million). Net profit attributable to Commerzbank shareholders stood at EUR209 million in the second quarter 2016 (Q2 2015: EUR307 million). Both are in line with consensus. The Common Equity Tier 1 ratio (CET 1) under full application of Basel 3 stood at 11.5% at the end of June 2016 (end of March 2016: 12.0%; end of June 2015: 10.5%) based on preliminary figures. This ratio includes a dividend accrual of 10 cents per share for the first half of 2016. The change in the CET1 ratio mainly results from the following non- operating valuation and methodology effects: - Higher risk-weighted assets (RWA) in particular for operational risks due to the consideration of new external events factored in by external databases representing industrywide damage claims of banks. - Higher pension liabilities due to lower discount factors (reduced from 2% to 1.7%) as well as higher capital deductions from revaluation reserves in particular driven by higher credit spreads for Italian sovereign debt. As already stated in the past, the capital ratio can be volatile in the current market environment. Commerzbank's ambition remains to keep its capital ratio under full application of Basel 3 above SREP-requirements. Figures shown in this release are preliminary. Commerzbank will publish its final figures for the second quarter 2016 on 2 August 2016. **** Disclaimer This release contains forward-looking statements. Forward-looking statements are statements that are not historical facts. In this release, these statements concern inter alia the expected future business of Commerzbank, efficiency gains and expected synergies, expected growth prospects and other opportunities for an increase in value of Commerzbank as well as expected future financial results, restructuring costs and other financial developments and information. These forward-looking statements are based on the management's current plans, expectations, estimates and projections. They are subject to a number of assumptions and involve known and unknown risks, uncertainties and other factors that may cause actual results and developments to differ materially from any future results and developments expressed or implied by such forward-looking statements. Such factors include the conditions in the financial markets in Germany, in Europe, in the USA and other regions from which Commerzbank derives a substantial portion of its revenues and in which Commerzbank holds a substantial portion of its assets, the development of asset prices and market volatility, especially due to the ongoing European debt crisis, potential defaults of borrowers or trading counterparties, the implementation of its strategic initiatives to improve its business model, particularly to reduce its ACR portfolio, the reliability of its risk management policies, procedures and methods, risks arising as a result of regulatory change and other risks. Forward-looking statements therefore speak only as of the date they are made. Commerzbank has no obligation to update or release any revisions to the forward-looking statements contained in this release to reflect events or circumstances after the date of this release. Contact: Commerzbank AG Group Communications Tel.: +49 69 136 - 22830 mediarelations@commerzbank.com 25.07.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: Commerzbank Aktiengesellschaft Kaiserstraße 16 60311 Frankfurt am Main Germany Phone: +49 (069) 136 20 Fax: - E-mail: ir@commerzbank.com Internet: www.commerzbank.de ISIN: DE000CBK1001 WKN: CBK100 Indices: DAX, CDAX, HDAX, PRIMEALL Listed: Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime Standard), Hamburg, Hanover, Munich, Stuttgart; Regulated Unofficial Market in Tradegate Exchange; Terminbörse EUREX; London, SIX End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lufax's Q3 Struggles: Rising Losses Amid Income Drop

Noteworthy Changes in Lufax's Financial Landscape Diving into Lufax's third quarter of 2026, it's clear as day that the numbers are drawing a grim picture. Lufax, a heavyweight in financial services for small business owners in China, announced unflattering financial results. The headline here? A net loss of RMB1,494 million, far from the RMB380 million lost the previous...

USDA Loans in Pampa: Clearing Up Misconceptions

Understanding USDA Loans in Pampa When it comes to buying a home in Pampa, Texas, there's a lot of chatter about USDA loans, and a fair bit of confusion too. Now, real estate expert Patti Hudson is cutting through the noise and setting the record straight, making sure families know all the facts before diving into the housing market. Not Just for Rural Areas Let's squash...

CapCut Leads 2026 AI Image Tools for Creatives

CapCut Emerges as a Go-To in AI Imagery There's no better feeling than striking gold in a flooded market. CapCut's got folks buzzing in 2026 for its top-tier AI image creation tools, according to Expert Consumers' latest rankings. On the surface, it might just seem like another tech gimmick, but dig a bit deeper, and you'll see why it's a game changer. From adland to...

New Ambulatory Surgery Center in Alabama Breaks Ground

Breaking New Ground: USOP and SOS Lead the Charge You can almost hear the construction noise starting up in Montgomery, Alabama, where U.S. Orthopaedic Partners (USOP) and Southern Orthopaedic Surgeons (SOS) have just launched an ambitious new project. They're not just cutting ceremonial ribbons; they're slicing into the future of orthopedic care in Central Alabama. The...

Liz Parrish's Bold Take on Gene Therapy and Aging

A Mother's Quest: From Personal Struggles to Professional Breakthroughs Never underestimate a mother's determination. When Liz Parrish's son was diagnosed with Type 1 diabetes, it sparked a relentless drive in her to find answers beyond conventional medicine. This journey led Parrish, CEO of BioViva Sciences USA Inc., not just into the cutting-edge world of gene therapy,...

oToBrite Unveils Avant-Garde Robotics Vision Tech at ROBOTWORLD

An Eye on the Future: oToBrite's Bold Vision for Robotics Strolling down the aisles at ROBOTWORLD 2026, there's a palpable energy buzzing around oToBrite's booth. These folks are showcasing vision technology that's not just about snapping slick photos—it's about reshaping how machines see the world. And, let me tell you, if there’s one place to flaunt cutting-edge...

Seasonal Hiring Booms as Firms Eye Long-Term Talent

A Strategic Shift in Seasonal Hiring It ain't just about the holiday rush anymore, folks. Companies are waking up to the idea that seasonal gigs are more than a temporary Band-Aid. This year, nearly 2 out of 5 companies are planning to bring more seasonal folks into the fold compared to last year. That means a good dose of them are looking for longer-term value—like...

Red Robin Faces Board Shakeup and Financial Strategy Shift

Turbulence on the Board But Strategic Moves on Track Well, it's not every day you hear about a double departure from Red Robin's board, right on the heels of some big financial reshuffling. Two directors, James C. Pappas and Christopher Martin, decided to abandon ship effective October 23, 2026. Given their ties to JCP Investment and Jumana Capital, this isn't just a...

Medical Device Manufacturing: $135B Market by 2031

Skyrocketing Demand in Medical Device Manufacturing You're looking at a market that's gearing up to hit a whopping $135.47 billion by 2031. That's a big leap from its $85.59 billion stature in 2026, showing a strong 9.6% compound annual growth rate (CAGR). Now, if that doesn't get your investor rollercoaster senses tingling, I don't know what will. Key Growth Drivers The...

UPM Defies Market Challenges: Strong Q3 Cash Flow

UPM's Impressive Q3 Performance Amidst Challenges UPM-Kymmene Corporation just dropped their Q3 numbers, and let me tell ya, there's a lot to digest. In the face of some pretty gnarly market conditions—think destocking and those pesky cost inflations—they've managed to pull a rabbit out of the hat with strong cash flow. That's not a small feat, folks; it's a damn...